1. Home
  2. GTBP vs IFBD Comparison

GTBP vs IFBD Comparison

Compare GTBP & IFBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.39

Market Cap

8.8M

Sector

Health Care

ML Signal

HOLD

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

N/A

Current Price

$0.91

Market Cap

8.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GTBP
IFBD
Founded
1965
2001
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.8M
8.5M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
GTBP
IFBD
Price
$0.39
$0.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
2.5K
Earning Date
05-15-2026
05-01-2023
Dividend Yield
N/A
N/A
EPS Growth
3.75
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.66
52 Week High
$3.73
$1.40

Technical Indicators

Market Signals
Indicator
GTBP
IFBD
Relative Strength Index (RSI) 51.65 37.32
Support Level $0.26 $0.66
Resistance Level $0.44 $1.09
Average True Range (ATR) 0.04 0.07
MACD 0.01 -0.01
Stochastic Oscillator 55.53 7.15

Price Performance

Historical Comparison
GTBP
IFBD

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

About IFBD Infobird Co. Ltd

Infobird Co Ltd is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. The Company provides standard and customized customer relationship management cloud-based services, including SaaS and business process outsourcing (BPO) services. It generates revenue from the development and sale of software licenses for customized software, as well as from business integration solution services and digital advertising and marketing campaign services. Digital advertising revenue is generated from developing and executing advertising plans based on customer needs, and the Company generally provides limited warranties for work performed under its business integration solution contracts. The Company generates maximum revenue from its operations in Mainland China.

Share on Social Networks: